1. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate Publication: Washington, DC : United States Government Accountability Office, September 2017 Subject(s): Anti-Bacterial Agents -- adverse effectsCommerce -- standardsDrug Residues -- standardsFishesFood Contamination -- prevention & controlFood SafetyFood Supply -- standardsHazard Analysis and Critical Control PointsSeafoodAquaculture -- standardsCatfishesFood Safety -- methodsGovernment RegulationPublic HealthHumansAsiaCanadaUnited StatesUnited States. Department of Agriculture.United States. Food and Drug Administration.
2. Low-wage workers: poverty and use of selected federal social safety net programs persist among working families : report to the ranking member, Subcommittee on Primary Health and Retirement Security, Committee on Health, Education, Labor, and Pensions, U.S. Senate Publication: Washington, DC : United States Government Accountability Office, September 2017 Subject(s): Employment -- statistics & numerical dataPoverty -- statistics & numerical dataPublic Assistance -- statistics & numerical dataPublic Assistance -- trendsAdultEducational StatusFood Assistance -- statistics & numerical dataForecastingIncome -- statistics & numerical dataIncome -- trendsIncome TaxMedicaid -- statistics & numerical dataMedicaid -- trendsMiddle AgedSafety-net ProvidersSalaries and Fringe Benefits -- statistics & numerical dataSalaries and Fringe Benefits -- trendsHumansUnited States
3. Climate change: information on potential economic effects could help guide federal efforts to reduce fiscal exposure : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, September 2017 Subject(s): Climate Change -- economicsGlobal Warming -- economicsModels, EconomicAgricultureCrimeElectric Power SuppliesEnvironmentGreenhouse EffectGreenhouse Gases -- adverse effectsHealthNatural ResourcesRisk AssessmentHumansUnited States
4. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate Publication: Washington, DC : United States Government Accountability Office, October 2017 Subject(s): Health Services AccessibilityOpiate Substitution TreatmentOpioid-Related Disorders -- drug therapyOutcome Assessment (Health Care)Community-Institutional RelationsBuprenorphine -- therapeutic useInservice TrainingInsurance CoverageMethadone -- therapeutic useNaloxone -- therapeutic useNaltrexone -- therapeutic usePrescription Drug Diversion -- prevention & controlHumansUnited StatesUnited States. Department of Health and Human Services.
5. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, October 2017 Subject(s): Analgesics, Opioid -- therapeutic useDrug Utilization ReviewGovernment RegulationInappropriate PrescribingMedicare Part DPrescription Drug MisuseFraud -- prevention & controlOpioid-Related DisordersHumansUnited StatesCenters for Medicare & Medicaid Services (U.S.)
6. Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives Publication: Washington, DC : United States Government Accountability Office, October 2017 Subject(s): Federal GovernmentHealth Benefit Plans, Employee -- statistics & numerical dataInsurance CarriersForecastingGovernment EmployeesHealth Benefit Plans, Employee -- trendsMedicareHumansUnited States
7. Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives Publication: Washington, DC : United States Government Accountability Office, October 2017 Subject(s): Drug and Narcotic Control -- organization & administrationDrug Trafficking -- prevention & controlGovernment AgenciesStreet DrugsDrug and Narcotic Control -- economicsDrug and Narcotic Control -- trendsForecastingInformation DisseminationInterinstitutional RelationsHumansNorth AmericaSouth AmericaUnited States
8. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, October 2017 Subject(s): Drug and Narcotic ControlPrescription Drug Diversion -- prevention & controlPrescription Drug Misuse -- prevention & controlVoluntary ProgramsGovernment ProgramsPharmaciesPrescription DrugsState GovernmentHumansUnited StatesUnited States. Drug Enforcement Administration.
9. Low-dose radiation: interagency collaboration on planning research could improve information on health effects : testimony before the Subcommittee on Energy, Committee on Science, Space, and Technology, House of Representatives Publication: Washington, DC : United States Government Accountability Office, November 1, 2017 Subject(s): Government AgenciesInterinstitutional RelationsRadiation EffectsRadiation, IonizingResearchRadiation DosageHumansUnited StatesUnited States. Department of Energy.United States. Environmental Protection Agency.United States. Food and Drug Administration.U.S. Nuclear Regulatory Commission.
10. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives Publication: Washington, DC : United States Government Accountability Office, November 2, 2017 Subject(s): Biological Warfare AgentsChemical Warfare AgentsGovernment RegulationLaboratoriesBacterial ToxinsInterinstitutional RelationsHumansCanadaUnited KingdomUnited StatesCenters for Disease Control and Prevention (U.S.)United States. Animal and Plant Health Inspection Service.
11. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): Child Welfare -- statistics & numerical dataChild Welfare -- trendsHealth PolicyInterinstitutional RelationsPolicy MakingSocial Determinants of HealthAccidents -- mortalityAdolescentAfrican AmericansAsthmaChildChild AbuseChild, PreschoolDepressionEarly Intervention (Education)European Continental Ancestry GroupEducational StatusFederal GovernmentFood SupplyForecastingGoalsHealth Services AccessibilityHealth StatusHispanic AmericansHomeless PersonsHousingInfantInsurance CoverageLocal GovernmentPovertyPregnancy OutcomeSmokingState GovernmentSubstance-Related DisordersSuicideHumansUnited States
12. Sunscreen: FDA reviewed applications for additional active ingredients and determined more data needed : report to Congressional committees Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): Drug ApprovalNonprescription DrugsSunscreening AgentsConsumer Product SafetyHumansUnited StatesUnited States. Food and Drug Administration.
13. Food safety: FDA continues to evaluate and respond to business concerns about the produce rule : report to Congressional committees Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): CommerceFood ContaminationFood SafetyFruitVegetablesWater PollutionWater SupplyHumansUnited StatesUnited States. Food and Drug Administration.
14. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): Clinical CompetenceGovernment RegulationHospitals, VeteransPatient SafetyQuality of Health CareDocumentationHealth PolicyVeterans HealthHumansUnited StatesUnited States. Veterans Health Administration.
15. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives Publication: Washington, DC : United States Government Accountability Office, November 29, 2017 Subject(s): Clinical CompetenceGovernment RegulationHospitals, VeteransPatient SafetyQuality of Health CareDocumentationVeterans HealthHumansUnited StatesUnited States. Veterans Health Administration.
16. Private school choice: federal actions needed to ensure parents are notified about changes in rights for students with disabilities : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): Civil RightsDisabled Children -- legislation & jurisprudenceSchools -- legislation & jurisprudenceStudents -- legislation & jurisprudenceDisclosureFederal GovernmentFinancing, GovernmentParentsPrivate SectorPublic SectorHumansUnited States
17. Veterans affairs contracting: improvements in buying medical and surgical supplies could yield cost savings and efficiency : report to the chairman, Committee on Veterans' Affairs, House of Representatives Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): Contract ServicesHospitals, VeteransPurchasing, HospitalCost SavingsEmergenciesEquipment and Supplies -- economicsHumansUnited StatesUnited States. Veterans Health Administration.
18. Health insurance exchanges: changes in benchmark plans and premiums and effects of automatic re-enrollment on consumers' costs : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): BenchmarkingConsumer BehaviorCosts and Cost AnalysisHealth Insurance Exchanges -- economicsInsurance, Health -- economicsEligibility DeterminationFinancing, PersonalHumansUnited StatesUnited States.
19. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, November 2017 Subject(s): Drug CostsDrug Industry -- economicsEconomics, Pharmaceutical -- trendsPharmaceutical Research -- economicsPharmaceutical Research -- trendsAntitrust LawsBiological Products -- economicsDrug Approval -- economicsDrug Development -- economicsDrug Development -- trendsEconomic CompetitionForecastingOrphan Drug Production -- economicsTaxesHumansUnited StatesNational Institutes of Health (U.S.)
20. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees Publication: Washington, DC : United States Government Accountability Office, December 2017 Subject(s): Fraud -- prevention & controlHealth Insurance ExchangesMedicaidMedicareRisk AssessmentRisk ManagementFraud -- economicsHumansUnited StatesUnited States. Department of Health and Human Services.Centers for Medicare & Medicaid Services (U.S.)State Children's Health Insurance Program (U.S.)